Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005)

Edith A. Perez, Michael F. Press, Amylou C. Dueck, Robert B. Jenkins, Chungyeul Kim, Beiyun Chen, Ivonne Villalobos, Soonmyung Paik, Marc Buyse, Anne E. Wiktor, Reid Meyer, Melanie Finnigan, Joanne Zujewski, Mona Shing, Howard M. Stern, Wilma L. Lingle, Monica M. Reinholz, Dennis J. Slamon

Research output: Contribution to journal › Article › peer-review

69 Scopus citations

Fingerprint

Dive into the research topics of 'Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005)'. Together they form a unique fingerprint.

Medicine & Life Sciences